Autism Spectrum Disorder Trial, Recruiting NCT06448767 Sponsor: Medical University of Warsaw Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06448767
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who have been diagnosed with Autism Spectrum Disorder (ASD) based on recognised medical diagnostic guidelines (DSM-5 or ICD-10)
  • Children who are either not currently taking any medication, or who have been on the same medication without changes for at least the past 2 months
  • Families who are willing to give written consent, have the child take nutritional supplements throughout the 3-month study, avoid starting any special diets during the study, and complete questionnaires at two points during the trial

Who may not be able to join:

  • Children who have taken antibiotic medicines (other than creams or ointments applied to the skin) in the 2 months before joining the trial
  • Children who have taken probiotics or synbiotics (supplements containing beneficial bacteria or related products) in the 2 months before joining
  • Children with a known intolerance or allergy to probiotics, synbiotics, or any other ingredient used in the study
  • Children who have had bowel surgery involving removal of part of the intestine, or who have a condition called short bowel syndrome
  • Children with a serious condition affecting the immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maja Kotowska, MD, Department of Paediatrics, The Medical University of Warsaw, Poland

Phone: +48223179536

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Warsaw
Registry
ClinicalTrials.gov
Start date
7 August 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

The Autism Spectrum Rating Scales (ASRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov